Nawaz Mahammed
Research Subjects
Nawaz Mahammed has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Abdullah Aljasser
Department of Pharmaceutics, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
1 shared publicationAbubakar Mohamedali Omer Idress
Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, Chiyyedu, Andhra Pradesh, INDIA
1 shared publicationAdel Al Fatease
Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha, Saudi Arabia
1 shared publicationAdil Farooq Wali
RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras Al Khaimah, United Arab Emirates
1 shared publicationAli H. Alamri
Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha, Saudi Arabia
1 shared publicationAmgad Gamal Abdulrahman Abbas
Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, Chiyyedu, Andhra Pradesh, INDIA
1 shared publication
Latest Publications
- Open Access
- 18 August 2026
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 16 (4) , 1384-1395
Recent Progress in 3D Printing of Pharmaceuticals: Personalized Medicine and On-Demand Dosage Forms
Additive manufacturing (also referred to as 3D printing, 3DP) has become a disruptive technology in the pharmaceutics industry, providing an opportunity to produce individualized and custom dosage forms on demand. In contrast to traditional manufacturing where batch production is used, 3DP has the ability to control drug dose, geometry, and release profiles accurately thereby managing interpatient variability and enhancing therapeutic outcomes. To show the clinical viability of 3D printed medicines, the FDA approval of Spritam® (levetiracetam) in 2015 was a milestone. Other types of 3DP technology, including inkjet printing, Fused Deposition Modelling (FDM), Selective Laser Sintering (SLS), stereolithography (SLA), and Semi-Solid Extrusion (SSE), have been effectively used to print custom formulation as polypills, orally disintegrating tablets, and implants. Such innovations can improve patient compliance, maximize pediatric, geriatric, and chronic disease therapy and point-of-care production in the hospital, pharmacy, and resource-limited environments. Regulatory, reproducibility, and scalability issues notwithstanding, in the recent past, the field of translational 3DP in pharmaceutics has been pointed out as a promising field of research. It is likely that artificial intelligence, digital health, and telepharmacy will continue to support its contribution to precision medicine. This review provides an overview of recent advances, policy implications, and case studies with a focus on how 3DP can transform the drug delivery model and define the future of personalized healthcare.
- 18 August 2026
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 16 (4) , 1384-1395
Open AccessRecent Progress in 3D Printing of Pharmaceuticals: Personalized Medicine and On-Demand Dosage Forms
Additive manufacturing (also referred to as 3D printing, 3DP) has become a disruptive technology in the pharmaceutics industry, providing an opportunity to produce individualized and custom dosage forms on demand. In contrast to traditional manufacturing where batch production is used, 3DP has the ability to control drug dose, geometry, and release profiles accurately thereby managing interpatient variability and enhancing therapeutic outcomes. To show the clinical viability of 3D printed medicines, the FDA approval of Spritam® (levetiracetam) in 2015 was a milestone. Other types of 3DP technology, including inkjet printing, Fused Deposition Modelling (FDM), Selective Laser Sintering (SLS), stereolithography (SLA), and Semi-Solid Extrusion (SSE), have been effectively used to print custom formulation as polypills, orally disintegrating tablets, and implants. Such innovations can improve patient compliance, maximize pediatric, geriatric, and chronic disease therapy and point-of-care production in the hospital, pharmacy, and resource-limited environments. Regulatory, reproducibility, and scalability issues notwithstanding, in the recent past, the field of translational 3DP in pharmaceutics has been pointed out as a promising field of research. It is likely that artificial intelligence, digital health, and telepharmacy will continue to support its contribution to precision medicine. This review provides an overview of recent advances, policy implications, and case studies with a focus on how 3DP can transform the drug delivery model and define the future of personalized healthcare.
- Open Access
- 25 June 2025
- Published by The University of Jordan in Jordan Journal of Pharmaceutical Sciences
- Vol. 18 (2) , 566-585
A Review on Puncturing Potential: Microneedles' Present Landscape And Prospective Horizons
Microneedle technology has emerged as a promising approach for drug delivery, vaccination, diagnostics, and cosmetic treatments. This review provides an overview of microneedle technology, covering the various types of microneedles, fabrication techniques, applications, advantages, challenges, safety considerations, clinical translation, and future perspectives. Solid, hollow, dissolving, coated, and hydrogel-forming microneedles are discussed, along with their structures, materials, and fabrication methods. Applications in drug delivery, vaccination, diagnostics, and cosmetic treatments are explored, with an emphasis on emerging and novel uses. The review highlights the advantages of microneedle technology, including enhanced patient compliance, improved drug absorption, and reduced pain, as well as challenges such as manufacturing scalability and regulatory approval. Fabrication techniques, biocompatibility, safety issues, clinical translation, and commercialization aspects are examined, along with future directions and emerging trends such as multifunctional microneedles and personalized medicine. Overall, microneedle technology holds tremendous promise for revolutionizing healthcare and biomedical engineering, but further research and development are required to address current challenges and realize its full potential.
- 25 June 2025
- Published by The University of Jordan in Jordan Journal of Pharmaceutical Sciences
- Vol. 18 (2) , 566-585
Open AccessA Review on Puncturing Potential: Microneedles' Present Landscape And Prospective Horizons
Microneedle technology has emerged as a promising approach for drug delivery, vaccination, diagnostics, and cosmetic treatments. This review provides an overview of microneedle technology, covering the various types of microneedles, fabrication techniques, applications, advantages, challenges, safety considerations, clinical translation, and future perspectives. Solid, hollow, dissolving, coated, and hydrogel-forming microneedles are discussed, along with their structures, materials, and fabrication methods. Applications in drug delivery, vaccination, diagnostics, and cosmetic treatments are explored, with an emphasis on emerging and novel uses. The review highlights the advantages of microneedle technology, including enhanced patient compliance, improved drug absorption, and reduced pain, as well as challenges such as manufacturing scalability and regulatory approval. Fabrication techniques, biocompatibility, safety issues, clinical translation, and commercialization aspects are examined, along with future directions and emerging trends such as multifunctional microneedles and personalized medicine. Overall, microneedle technology holds tremendous promise for revolutionizing healthcare and biomedical engineering, but further research and development are required to address current challenges and realize its full potential.
- Open Access
- 26 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Enhanced colon-targeted drug delivery through development of 5-fluorouracil-loaded cross-linked mastic gum nanoparticles
This study explored the development of a novel colon-specific drug delivery system for 5-fluorouracil (5-FU) using cross-linked mastic gum (MG) nanoparticles (NPs). The primary goal is to enhance the treatment efficacy of colon cancer while minimizing systemic side effects. We employed Fourier Transform Infrared Radiation (FTIR) and Scanning Electron Microscopy (SEM) for the detailed characterization of the samples. FTIR analysis confirmed the successful cross-linking of MG, whereas SEM images revealed the spherical and uniform morphology of the NPs. Additionally, analysis of drug encapsulation efficiency (83.53%), particle size (240 nm), and drug release kinetics (zero-order), and the drug release percentage (95.20% ) were analyzed. The results demonstrated that MG NPs effectively encapsulated and controlled the release of 5-FU in a colon-targeted manner. This study recommends the proposed drug delivery system because of its potential to improve the outcomes of colon cancer treatment.
- 26 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessEnhanced colon-targeted drug delivery through development of 5-fluorouracil-loaded cross-linked mastic gum nanoparticles
This study explored the development of a novel colon-specific drug delivery system for 5-fluorouracil (5-FU) using cross-linked mastic gum (MG) nanoparticles (NPs). The primary goal is to enhance the treatment efficacy of colon cancer while minimizing systemic side effects. We employed Fourier Transform Infrared Radiation (FTIR) and Scanning Electron Microscopy (SEM) for the detailed characterization of the samples. FTIR analysis confirmed the successful cross-linking of MG, whereas SEM images revealed the spherical and uniform morphology of the NPs. Additionally, analysis of drug encapsulation efficiency (83.53%), particle size (240 nm), and drug release kinetics (zero-order), and the drug release percentage (95.20% ) were analyzed. The results demonstrated that MG NPs effectively encapsulated and controlled the release of 5-FU in a colon-targeted manner. This study recommends the proposed drug delivery system because of its potential to improve the outcomes of colon cancer treatment.
- Open Access
- 23 April 2025
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 15 (3) , 759-769
Quantum Dots in Nanotechnology: Advances in Therapeutics, Drugs Delivery and Imaging
Quantum Dots (QDs), semiconductor nanoparticles, exhibit unique optical properties like excellent photostability, high brightness, and size-tuneable emission wavelengths due to quantum confinement. Their broad absorption and narrow emission spectra make them ideal for high-resolution, multicoloured imaging in biological and medical applications. QDs are increasingly used in cellular, molecular, and in vivo imaging, as well as diagnostic techniques for cancer and pathogen detection. Additionally, they hold promise for targeted drug delivery, where surface functionalization with biomolecules allows precise targeting. However, concerns about QD toxicity, influenced by surface coatings and size, remain. Research into biocompatible coatings is essential to address safety concerns. Future advancements in QD synthesis, functionalization, and integration with nanotechnologies will further enhance their potential in personalized medicine. Overcoming regulatory and safety challenges is critical for their clinical adoption.
- 23 April 2025
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 15 (3) , 759-769
Open AccessQuantum Dots in Nanotechnology: Advances in Therapeutics, Drugs Delivery and Imaging
Quantum Dots (QDs), semiconductor nanoparticles, exhibit unique optical properties like excellent photostability, high brightness, and size-tuneable emission wavelengths due to quantum confinement. Their broad absorption and narrow emission spectra make them ideal for high-resolution, multicoloured imaging in biological and medical applications. QDs are increasingly used in cellular, molecular, and in vivo imaging, as well as diagnostic techniques for cancer and pathogen detection. Additionally, they hold promise for targeted drug delivery, where surface functionalization with biomolecules allows precise targeting. However, concerns about QD toxicity, influenced by surface coatings and size, remain. Research into biocompatible coatings is essential to address safety concerns. Future advancements in QD synthesis, functionalization, and integration with nanotechnologies will further enhance their potential in personalized medicine. Overcoming regulatory and safety challenges is critical for their clinical adoption.
- Open Access
- 1 March 2025
- Published by BRNSS Publication Hub in Asian Journal of Pharmaceutics
- Vol. 19 (01)
Stimuli-responsive nanomaterials: Innovations in on-demand drug release systems
Stimuli-responsive nanoparticles (SRNs) provide an innovative method in pharmaceuticals, facilitating accurate, on-demand drug release systems customized for particular therapeutic requirements. These sophisticated materials react to internal (pH, enzymes, and redox potential) or exterior (temperature, light, and magnetic fields) stimuli, enabling regulated drug release while reducing adverse effects. Recent developments in the design and engineering of SRNs have improved their sensitivity, biocompatibility, and drug-loading efficiency, rendering them optimal candidates for customized therapy. Notwithstanding their potential, issues related to stability, possible cytotoxicity, and scalability impede their clinical application. Contemporary research emphasizes surmounting these obstacles using multistimuli-responsive systems and the use of developing technologies such as artificial intelligence. This review elucidates the processes, material developments, and pharmacological applications of SRNs, addresses significant limits, and examines prospective avenues for their advancement. By tackling these issues, SRNs possess the capacity to revolutionize contemporary drug delivery methods, providing unparalleled precision and efficiency in therapeutic treatments.
- 1 March 2025
- Published by BRNSS Publication Hub in Asian Journal of Pharmaceutics
- Vol. 19 (01)
Open AccessStimuli-responsive nanomaterials: Innovations in on-demand drug release systems
Stimuli-responsive nanoparticles (SRNs) provide an innovative method in pharmaceuticals, facilitating accurate, on-demand drug release systems customized for particular therapeutic requirements. These sophisticated materials react to internal (pH, enzymes, and redox potential) or exterior (temperature, light, and magnetic fields) stimuli, enabling regulated drug release while reducing adverse effects. Recent developments in the design and engineering of SRNs have improved their sensitivity, biocompatibility, and drug-loading efficiency, rendering them optimal candidates for customized therapy. Notwithstanding their potential, issues related to stability, possible cytotoxicity, and scalability impede their clinical application. Contemporary research emphasizes surmounting these obstacles using multistimuli-responsive systems and the use of developing technologies such as artificial intelligence. This review elucidates the processes, material developments, and pharmacological applications of SRNs, addresses significant limits, and examines prospective avenues for their advancement. By tackling these issues, SRNs possess the capacity to revolutionize contemporary drug delivery methods, providing unparalleled precision and efficiency in therapeutic treatments.
- Open Access
Permeability-Enhanced Liposomal Emulgel Formulation of 5-Fluorouracil for the Treatment of Skin Cancer
The plain 5-fluorouracil (5FU) formulations available in the market are associated with adverse effects such as skin irritation, pruritus, redness, blisters, allergy, and dryness on the site of application. The objective of the present study was to develop a liposomal emulgel of 5FU with increased skin permeability and efficacy using clove oil and eucalyptus oil along with pharmaceutically acceptable carriers, excipients, stabilizers, binders, and additives. A series of seven formulations were developed and evaluated for their entrapment efficiency, in vitro release profile, and cumulative drug release profile. The compatibility of drugs and excipients, as confirmed by FTIR (fourier-transform infrared spectroscopy) and DSC (differential scanning calorimetry) as well as SEM (scanning electron microscopy) and TEM (transmission electron microscopy) studies, revealed that the size and shape of liposomes are smooth and spherical, and the liposomes are non-aggregated. To understand their efficacy, the optimized formulations were evaluated for cytotoxicity using B16-F10 mouse skin melanoma cells. The eucalyptus oil and clove oil-containing preparation significantly produced a cytotoxic effect against a melanoma cell line. The addition of clove oil and eucalyptus oil increased the efficacy of the formulation by improving skin permeability and reducing the dose required for the anti-skin cancer activity.
Open AccessPermeability-Enhanced Liposomal Emulgel Formulation of 5-Fluorouracil for the Treatment of Skin Cancer
The plain 5-fluorouracil (5FU) formulations available in the market are associated with adverse effects such as skin irritation, pruritus, redness, blisters, allergy, and dryness on the site of application. The objective of the present study was to develop a liposomal emulgel of 5FU with increased skin permeability and efficacy using clove oil and eucalyptus oil along with pharmaceutically acceptable carriers, excipients, stabilizers, binders, and additives. A series of seven formulations were developed and evaluated for their entrapment efficiency, in vitro release profile, and cumulative drug release profile. The compatibility of drugs and excipients, as confirmed by FTIR (fourier-transform infrared spectroscopy) and DSC (differential scanning calorimetry) as well as SEM (scanning electron microscopy) and TEM (transmission electron microscopy) studies, revealed that the size and shape of liposomes are smooth and spherical, and the liposomes are non-aggregated. To understand their efficacy, the optimized formulations were evaluated for cytotoxicity using B16-F10 mouse skin melanoma cells. The eucalyptus oil and clove oil-containing preparation significantly produced a cytotoxic effect against a melanoma cell line. The addition of clove oil and eucalyptus oil increased the efficacy of the formulation by improving skin permeability and reducing the dose required for the anti-skin cancer activity.